H HAEMONETICS CORP MASS
| Market Cap | $3.01B |
| P/E Ratio | 17.69 |
| Forward P/E | 12.07 |
| Dividend Yield | — |
| Beta | 0.31 |
| 52W Range | $47.32 - $87.32 |
| # Hedge Funds | 0 |
| Sector | Healthcare |
| Industry | Medical Devices |
Hedge Fund Ownership
| Investor 0 | % of Portfolio Weight of this stock in the investor's portfolio | Value Total dollar value of the position | Shares Number of shares held | Activity Portfolio change type: New, Increased, Decreased, or Sold |
|---|
Insider Trading
| Insider Name of the company insider who made the trade 1 | Type Purchase (buy) or Sale (sell) | Shares Number of shares traded | Price Price per share at time of transaction | Value Total dollar value of the transaction | Trade Date Date the transaction was executed | Filing Date Date the SEC filing was submitted |
|---|---|---|---|---|---|---|
| KROLL MARK W | Buy | 1,400 | $70.56 | $98.78K | 10 Nov 2025 | 12 Nov 2025 |
Frequently Asked Questions
What is HAE stock price today?
HAEMONETICS CORP MASS (HAE) is currently trading at $64.23. The stock has a 52-week range of $47.32 to $87.32 and a market capitalization of $3.01B.
Is HAE a good stock to buy in 2026?
HAEMONETICS CORP MASS has a P/E ratio of 17.7 (forward P/E: 12.1), a dividend yield of none, and 1-year performance of -5.6%. 0 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.
Are insiders buying or selling HAE stock?
There have been 1 insider transactions for HAE in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.
How has HAE stock performed over the past year?
HAEMONETICS CORP MASS (HAE) has returned -5.6% over the past 12 months. The stock traded between $47.32 and $87.32 during this period, and is currently at $64.23.
Which hedge funds own HAE (HAEMONETICS CORP MASS)?
0 tracked hedge funds currently hold HAE in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.
What is HAE's market cap and valuation?
HAEMONETICS CORP MASS (HAE) has a market capitalization of $3.01B. The trailing P/E ratio is 17.7 and forward P/E is 12.1. The stock is classified in the Healthcare sector.
What is HAE's revenue and profitability?
HAEMONETICS CORP MASS reported revenue of $1.32B with net income of $175.44M and a profit margin of 0.13%. The stock has a beta of 0.31.
What sector is HAE in and who are its biggest institutional holders?
HAEMONETICS CORP MASS (HAE) operates in the Healthcare sector. It is held by 0 tracked hedge funds. See the ownership table above for the complete list.